Details of Protein
General Information of Protein (ID: PRT01686) | |||||
---|---|---|---|---|---|
Name | Protein snail homolog 1 (SNAI1) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
Zinc finger protein SNAI1; Protein sna; SNAH
|
||||
Gene Name | SNAI1 | Gene ID | |||
UniProt ID | |||||
Family | Zinc finger protein (ZIN) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MPRSFLVRKPSDPNRKPNYSELQDSNPEFTFQQPYDQAHLLAAIPPPEILNPTASLPMLI
WDSVLAPQAQPIAWASLRLQESPRVAELTSLSDEDSGKGSQPPSPPSPAPSSFSSTSVSS LEAEAYAAFPGLGQVPKQLAQLSEAKDLQARKAFNCKYCNKEYLSLGALKMHIRSHTLPC VCGTCGKAFSRPWLLQGHVRTHTGEKPFSCPHCSRAFADRSNLRAHLQTHSDVKKYQCQA CARTFSRMSLLHKHQESGCSGCPR |
||||
Structure | |||||
Function | Involved in induction of the epithelial to mesenchymal transition (EMT), formation and maintenance of embryonic mesoderm, growth arrest, survival and cell migration. Binds to 3 E-boxes of the E-cadherin/CDH1 gene promoter and to the promoters of CLDN7 and KRT8 and, in association with histone demethylase KDM1A which it recruits to the promoters, causes a decrease in dimethylated H3K4 levels and represses transcription (PubMed:20389281, PubMed:20562920). The N-terminal SNAG domain competes with histone H3 for the same binding site on the histone demethylase complex formed by KDM1A and RCOR1, and thereby inhibits demethylation of histone H3 at 'Lys-4' (in vitro) (PubMed:20389281, PubMed:21300290, PubMed:23721412). During EMT, involved with LOXL2 in negatively regulating pericentromeric heterochromatin transcription (By similarity). SNAI1 recruits LOXL2 to pericentromeric regions to oxidize histone H3 and repress transcription which leads to release of heterochromatin component CBX5/HP1A, enabling chromatin reorganization and acquisition of mesenchymal traits (By similarity). Associates with EGR1 and SP1 to mediate tetradecanoyl phorbol acetate (TPA)-induced up-regulation of CDKN2B, possibly by binding to the CDKN2B promoter region 5'-TCACA-3. In addition, may also activate the CDKN2B promoter by itself. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Nucleosides, nucleotides, and analogues | ||||||
NAD | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (shRNA) of SNAI1 | |||||
Induced Change | NAD concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockdown of Snai1 leads to the increase of NAD levels compared with control group. | |||||
Organic acids and derivatives | ||||||
Creatine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (shRNA) of SNAI1 | |||||
Induced Change | Creatine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockdown of Snai1 leads to the increase of creatine levels compared with control group. | |||||
Formic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (shRNA) of SNAI1 | |||||
Induced Change | Formic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockdown of Snai1 leads to the increase of formic acid levels compared with control group. | |||||
Glutamic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (shRNA) of SNAI1 | |||||
Induced Change | Glutamic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockdown of Snai1 leads to the increase of glutamic acid levels compared with control group. | |||||
Glycine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (shRNA) of SNAI1 | |||||
Induced Change | Glycine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockdown of Snai1 leads to the increase of glycine levels compared with control group. | |||||
Lactic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (shRNA) of SNAI1 | |||||
Induced Change | Lactic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockdown of Snai1 leads to the increase of lactic acid levels compared with control group. | |||||
Proline | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (shRNA) of SNAI1 | |||||
Induced Change | Proline concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockdown of Snai1 leads to the increase of proline levels compared with control group. | |||||
Taurine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (shRNA) of SNAI1 | |||||
Induced Change | Taurine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockdown of Snai1 leads to the increase of taurine levels compared with control group. | |||||
Tyrosine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (shRNA) of SNAI1 | |||||
Induced Change | Tyrosine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockdown of Snai1 leads to the increase of tyrosine levels compared with control group. | |||||
Valine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (shRNA) of SNAI1 | |||||
Induced Change | Valine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockdown of Snai1 leads to the increase of valine levels compared with control group. | |||||
Organic nitrogen compounds | ||||||
Choline | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (shRNA) of SNAI1 | |||||
Induced Change | Choline concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockdown of Snai1 leads to the increase of choline levels compared with control group. | |||||
Phosphorylcholine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (shRNA) of SNAI1 | |||||
Induced Change | Phosphorylcholine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockdown of Snai1 leads to the increase of phosphorylcholine levels compared with control group. | |||||
Organic oxygen compounds | ||||||
myo-Inositol | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (shRNA) of SNAI1 | |||||
Induced Change | myo-Inositol concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] | |||||
Details | It is reported that knockdown of Snai1 leads to the increase of myo-inositol levels compared with control group. | |||||
References | |||||
---|---|---|---|---|---|
1 | Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress. Nat Commun. 2017 Feb 8;8:14374. |
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.